The Impact of Genomic Changes on Treatment of Lung Cancer

nork Cardarella, Stephanie, Johnson, Bruce E.
Argitaratua 2013

Race, Poverty, and Initial Implementation of Precision Medicine for Lung Cancer

nork Kehl, Kenneth L, Lathan, Christopher S, Johnson, Bruce E, Schrag, Deborah
Argitaratua izan da J Natl Cancer Inst (2018)

State of the Art: Response Assessment in Lung Cancer in the Era of Genomic Medicine

nork Nishino, Mizuki, Hatabu, Hiroto, Johnson, Bruce E., McLoud, Theresa C.
Argitaratua izan da Radiology (2014)

Parity and Risk of Lung Cancer in Women

nork Paulus, Jessica K., Asomaning, Kofi, Kraft, Peter, Johnson, Bruce E., Lin, Xihong, Christiani, David C.
Argitaratua 2010

Haplotypes of Estrogen Receptor Beta and risk of Non-small cell lung cancer in women

nork Paulus, Jessica K., Zhou, Wei, Kraft, Peter, Johnson, Bruce E., Lin, Xihong, Christiani, David C.
Argitaratua 2010

Factors associated with smoking abstinence among smokers and recent-quitters with lung and head and neck cancer

nork Cooley, Mary E., Wang, Qian, Johnson, Bruce E., Catalano, Paul, Haddad, Robert I., Bueno, Raphael, Emmons, Karen M.
Argitaratua 2011

Imaging of Lung Cancer in the Era of Molecular Medicine

nork Nishino, Mizuki, Jackman, David M., Hatabu, Hiroto, Jänne, Pasi A., Johnson, Bruce E., Van den Abbeele, Annick D.
Argitaratua 2011

Automated image analysis tool for tumor volume growth rate to guide precision cancer therapy: EGFR-mutant non-small-cell lung cancer as a paradigm

nork Nishino, Mizuki, Wakai, Satoshi, Hida, Tomoyuki, Dahlberg, Suzanne E., Ozaki, Masahiro, Hatabu, Hiroto, Tachizaki, Hisashi, Johnson, Bruce E.
Argitaratua izan da Eur J Radiol (2018)

Performance of a Machine Learning Algorithm Using Electronic Health Record Data to Identify and Estimate Survival in a Longitudinal Cohort of Patients With Lung Cancer

nork Yuan, Qianyu, Cai, Tianrun, Hong, Chuan, Du, Mulong, Johnson, Bruce E., Lanuti, Michael, Cai, Tianxi, Christiani, David C.
Argitaratua izan da JAMA Netw Open (2021)

Development of Central Nervous System Metastases in Patients with Advanced Non-Small Cell Lung Cancer and Somatic EGFR Mutations Treated with Gefitinib or Erlotinib

nork Heon, Stephanie, Yeap, Beow Y., Britt, Gregory J., Costa, Daniel B., Rabin, Michael S., Jackman, David M., Johnson, Bruce E.
Argitaratua 2010

Unsuspected pulmonary embolism in lung cancer patients: Comparison of clinical characteristics and outcome with suspected pulmonary embolism

nork Shinagare, Atul B., Okajima, Yuka, Oxnard, Geoffrey R., DiPiro, Pamela J., Johnson, Bruce E., Hatabu, Hiroto, Nishino, Mizuki
Argitaratua 2012

Volumetric tumor response and progression in EGFR-mutant NSCLC patients treated with erlotinib or gefitinib

nork Nishino, Mizuki, Dahlberg, Suzanne E., Fulton, Linnea E., Digumarthy, Subba R., Hatabu, Hiroto, Johnson, Bruce E., Sequist, Lecia V.
Argitaratua izan da Acad Radiol (2016)

Interstitial lung abnormality in stage IV non-small cell lung cancer: A validation study for the association with poor clinical outcome

nork Araki, Tetsuro, Dahlberg, Suzanne E., Hida, Tomoyuki, Lydon, Christine A., Rabin, Michael S., Hatabu, Hiroto, Johnson, Bruce E., Nishino, Mizuki
Argitaratua izan da Eur J Radiol Open (2019)

M1b Disease in the 8th Edition of TNM Staging of Lung Cancer: Pattern of Single Extrathoracic Metastasis and Clinical Outcome

nork Park, Hyesun, Dahlberg, Suzanne E., Lydon, Christine A., Araki, Tetsuro, Hatabu, Hiroto, Rabin, Michael S., Johnson, Bruce E., Nishino, Mizuki
Argitaratua izan da Oncologist (2019)

Patient report of receipt and interest in smoking cessation interventions after a diagnosis of cancer

nork Cooley, Mary E., Emmons, Karen M., Haddad, Robert, Wang, Qian, Posner, Marshall, Bueno, Raphael, Cohen, Tiffany-Jen, Johnson, Bruce E.
Argitaratua 2011

Tumoral cavitation in patients with non-small-cell lung cancer treated with antiangiogenic therapy using bevacizumab

nork Nishino, Mizuki, Cryer, Sarah K., Okajima, Yuka, Sholl, Lynette M., Hatabu, Hiroto, Rabin, Michael S., Jackman, David M., Johnson, Bruce E.
Argitaratua 2012

Tumor Volume Decrease at 8 weeks is Associated with Longer Survival in EGFR-mutant Advanced Non-Small-Cell Lung Cancer Patients treated with EGFR Tyrosine Kinase Inhibitor

nork Nishino, Mizuki, Dahlberg, Suzanne E., Cardarella, Stephanie, Jackman, David M., Rabin, Michael S., Hatabu, Hiroto, Jänne, Pasi A., Johnson, Bruce E.
Argitaratua 2013

RECIST 1.1 in NSCLC Patients With EGFR Mutations Treated With EGFR Tyrosine Kinase Inhibitors: Comparison With RECIST 1.0

nork Nishino, Mizuki, Cardarella, Stephanie, Jackman, David M., Ramaiya, Nikhil H., Rabin, Michael S., Hatabu, Hiroto, Jänne, Pasi A., Johnson, Bruce E.
Argitaratua 2013

Five-year survival in EGFR-mutant metastatic lung adenocarcinoma treated with EGFR-TKIs

nork Lin, Jessica J., Cardarella, Stephanie, Lydon, Christine A., Dahlberg, Suzanne E., Jackman, David M., Jänne, Pasi A., Johnson, Bruce E.
Argitaratua izan da J Thorac Oncol (2015)

Tumor volume dynamics and tumor growth rate in ALK-rearranged advanced non-small-cell lung cancer treated with crizotinib

nork Nishino, Mizuki, Hida, Tomoyuki, Kravets, Sasha, Dahlberg, Suzanne E., Lydon, Christine A., Hatabu, Hiroto, Johnson, Bruce E., Awad, Mark M.
Argitaratua izan da Eur J Radiol Open (2020)